Titelia

Holdings of Nextech Invest, Ltd.

16 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 96.9 % of the equity sleeve

Sector breakdown

  • Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 99.6 %
  • GB 0.4 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US151.4B $99.64 %
2GB15M $0.36 %

Positions

RankCompanySharesValueWeight
1Revolution Medicines Inc 7,601,087739.2M $
2Tyra Biosciences Inc 4,055,861155.3M $
3Tango Therapeutics Inc 7,266,081152M $
4ORIC Pharmaceuticals Inc 7,162,63790.8M $
5Alumis Inc 3,540,99878M $
6Relay Therapeutics Inc 5,526,50655M $
7Zymeworks Inc 1,113,94627.9M $
8Kymera Therapeutics Inc 278,89623.2M $
9CytomX Therapeutics Inc 4,449,93220.9M $
10Context Therapeutics Inc 7,419,35519.4M $
11Cullinan Therapeutics Inc 1,141,14516.2M $
12Corvus Pharmaceuticals Inc 450,0006.6M $
13Arvinas Inc 539,3945.7M $
14Silence Therapeutics PLC 952,4005M $
15Monte Rosa Therapeutics Inc 304,2375M $
16ARS Pharmaceuticals Inc 610,7034.9M $